Frequently Asked Questions
The market is segmented based on Segmentation, By Drugs (Isoniazid, Ethambutol, Rifampin, Clarithromycin, Azithromycin, Rifabutim, Ethambutol, Streptomycin, Amikacin and Others), Bacteria Type (M. Tuberculosis, M. Leprae, Non-tuberculosis Mycobacteria, and Others), Indication (Tuberculosis, Leprosy, and Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) – Industry Trends and Forecast to 2031
.
The Global Mycobacterium Abscessus Treatment Market size was valued at USD 491.98 USD Million in 2023.
The Global Mycobacterium Abscessus Treatment Market is projected to grow at a CAGR of 7.67% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
